icon
沙特阿拉伯王国政府所属的官方政府网站。
icon 周四 13 八月 2026
icon
沙特官方政府网站的域名以下列后缀结尾 gov.sa

沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

在数字政府管理局注册,编号:

20250831619
建议

A double blind, Double Dummy, Randomized, Multi-Centre study to assess the tolerability and Efficacy Profile of Vildagliptin Compared to Gliclazide as Dual Therapy with Metformin in Muslim Patients with Type 2 Diabetes Fasting During Ramadan.

A double blind, Double Dummy, Randomized, Multi-Centre study to assess the tolerability and Efficacy Profile of Vildagliptin Compared to Gliclazide as Dual Therapy with Metformin in Muslim Patients with Type 2 Diabetes Fasting During Ramadan.

icon 2020-07-04
عنوان الدراسة
A double blind, Double Dummy, Randomized, Multi-Centre study to assess the tolerability and Efficacy Profile of Vildagliptin Compared to Gliclazide as Dual Therapy with Metformin in Muslim Patients with Type 2 Diabetes Fasting During Ramadan.
داعم الدراسة
Novartis
دواء الدراسة
Vildagliptin /Gliclazide / Metformin
رقم بروتوكول الدراسة
CLAF237A2411
حالة الدراسة
Completed
موقع الدراسة
King Fahad University Hospital (Al-Khobar)_ King Abdulaziz Medical City NG (Riyadh)
مرحلة الدراسة
4